Kim, MJ, Divatia, MK, Lee, JH, Shen, S, Miles, BJ, Hwang, JH, Ayala, AG, Ro, JY. Collagenous Micronodules in Prostate Cancer Revisited: Are They Solely Associated with Gleason Pattern 3 Adenocarcinomas? Int J Clin Exp Pathol. 2015 Apr 1; 8(4): 3469–76.Google Scholar

Santoni, M, Scarpelli, M, Mazzucchelli, R, Lopez-Beltran, A, Cheng, L, Epstein, JI, Cascinu, S, Briganti, A, Catto, JW, Montorsi, F, Montironi, R. Current Histopathologic and Molecular Characterisations of Prostate Cancer: Towards Individualised Prognosis and Therapies. Eur Urol. 2016 Feb; 69(2): 186–90.CrossRefGoogle ScholarPubMed

Mazzucchelli, R, Galosi, AB, Santoni, M, Lopez-Beltran, A, Scarpelli, M, Cheng, L, Montironi, R. Role of the Pathologist in Active Surveillance for Prostate Cancer. Anal Quant Cytopathol Histpathol. 2015 Feb; 37(1): 65–68.Google Scholar

Epstein, JI, Egevad, L, Amin, MB, Delahunt, B, Srigley, JR, Humphrey, PA. Grading Committee. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Am J Surg Pathol. 2016 Feb; 40(2): 244–52. doi: 10.1097/PAS.0000000000000530.CrossRefGoogle Scholar

Gasparrini, S, Mazzucchelli, R, Scarpelli, M, Massari, F, Raspollini, MR, Lopez-Beltran, A, Cheng, L, Montironi, R. Prostate Cancer Grading in 2016. Minerva Urol Nefrol. 2016 Nov 4; [Epub ahead of print].CrossRefGoogle Scholar

Berney, DM, Algaba, F, Camparo, P, Compérat, E, Griffiths, D, Kristiansen, G, Lopez-Beltran, A, Montironi, R, Varma, M, Egevad, L. Variation in Reporting of Cancer Extent and Benign Histology in Prostate Biopsies among European Pathologists. Virchows Arch. 2014 Mar 4; [Epub ahead of print].CrossRefGoogle Scholar

Montironi, R, Cheng, L, Lopez-Beltran, A, Montironi, MA, Galosi, AB, Scarpelli, M. A Low Grade PIN-like Neoplasm of the Transition Zone Immunohistochemically Negative for Basal Cell Markers: A Possible Example of Low Grade Adenocarcinoma with Stratified Epithelium. Pathology. 2014 Jan; 46(1): 88–91.Google Scholar

Berney, DM, Algaba, F, Camparo, P, Compérat, E, Griffiths, D, Kristiansen, G, Lopez-Beltran, A, Montironi, R, Varma, M, Egevad, L. The Reasons behind Variation in Gleason Grading of Prostatic Biopsies: Areas of Agreement and Misconception among 266 European Pathologists. Histopathology. 2014 Feb; 64(3): 405–11. doi: 10.1111/his.12284. Epub 2013 Nov 6.Google Scholar

Yossepowitch, O, Briganti, A, Eastham, JA, Epstein, J, Graefen, M, Montironi, R, Touijer, K. Positive Surgical Margins after Radical Prostatectomy: A Systematic Review and Contemporary Update. Eur Urol. 2014 Feb; 65(2): 303–13. doi: 10.1016/j.eururo.2013.07.039. Epub 2013 Aug 3.Google Scholar

Schelling, LA, Williamson, SR, Zhang, S, Yao, JL, Wang, M, Huang, J, Montironi, R, Lopez-Beltran, A, Emerson, RE, Idrees, MT, Osunkoya, AO, Man, YG, Maclennan, GT, Baldridge, LA, Compérat, E, Cheng, L. Frequent TMPRSS2-ERG Rearrangement in Prostatic Small Cell Carcinoma Detected by Fluorescence in Situ Hybridization: The Superiority of Fluorescence in Situ Hybridization over ERG Immunohistochemistry. Hum Pathol. 2013 Oct; 44(10): 2227–33. doi: 10.1016/j.humpath.2013.05.005. Epub 2013 Jul 12.Google Scholar

Montironi, R, Cheng, L, Lopez-Beltran, A, Mazzucchelli, R, Scarpelli, M. Combined Handling of Prostate Base/Bladder Neck and Seminal Vesicles in Radical Prostatectomy Specimens: Our Approach with the Whole Mount Technique. Histopathology. 2013 Sep; 63(3): 431–35. doi: 10.1111/his.12158. Epub 2013 Jun 24. No abstract available.Google Scholar

Montironi, R, Lopez-Beltran, A, Cheng, L, Montorsi, F, Scarpelli, M. Central Prostate Pathology Review: Should It Be Mandatory? Eur Urol. 2013 Aug; 64(2): 199–201. Discussion 202–03. doi: 10.1016/j.eururo.2013.04.002. Epub 2013 Apr 16. No abstract available.Google Scholar

Montironi, R, Scarpelli, M, Cheng, L, Lopez-Beltran, A, Montorsi, F, Kirkali, Z. Somatostatin Receptor Expression in Prostate Carcinoma: The Urological Pathologist’s Role in the Era of Personalised Medicine. Pathology. 2013 Jan; 45(1): 93–96. doi: 10.1097/PAT.0b013e32835bae76. No abstract available.Google Scholar

Cheng, L, MacLennan, GT, Lopez-Beltran, A, Montironi, R. Anatomic, Morphologic and Genetic Heterogeneity of Prostate Cancer: Implications for Clinical Practice. Expert Rev Anticancer Ther. 2012 Nov; 12(11): 1371–74. doi: 10.1586/era.12.127.Google Scholar

Egevad, L, Ahmad, AS, Algaba, F, Berney, DM, Boccon-Gibod, L, Compérat, E, Evans, AJ, Griffiths, D, Grobholz, R, Kristiansen, G, Langner, C, Lopez-Beltran, A, Montironi, R, Moss, S, Oliveira, P, Vainer, B, Varma, M, Camparo, P. Standardization of Gleason Grading among 337 European Pathologists. Histopathology. 2013 Jan; 62(2): 247–56. doi: 10.1111/his.12008.Google Scholar

Varma, M, Berney, DM, Algaba, F, Camparo, P, Compérat, E, Griffiths, DF, Kristiansen, G, Lopez-Beltran, A, Montironi, R, Egevad, L. Prostate Needle Biopsy Processing: A Survey of Laboratory Practice across Europe. J Clin Pathol. 2013 Feb; 66(2): 120–23. doi: 10.1136/jclinpath-2012-200993.CrossRefGoogle ScholarPubMed

Brimo, F, Montironi, R, Egevad, L, Erbersdobler, A, Lin, DW, Nelson, JB, Rubin, MA, van der Kwast, T, Amin, M, Epstein, JI. Contemporary Grading for Prostate Cancer: Implications for Patient Care. Eur Urol. 2013 May; 63(5): 892–901. doi: 10.1016/j.eururo.2012.10.015.CrossRefGoogle ScholarPubMed

Ukimura, O, Coleman, JA, de la Taille, A, Emberton, M, Epstein, JI, Freedland, SJ, Giannarini, G, Kibel, AS, Montironi, R, Ploussard, G, Roobol, MJ, Scattoni, V, Jones, JS. Contemporary Role of Systematic Prostate Biopsies: Indications, Techniques, and Implications for Patient Care. Eur Urol. 2013 Feb; 63(2): 214–30. doi: 10.1016/j.eururo.2012.09.033.Google Scholar

Quick, Charles M. MDa, Gokden, N., Sangoi, Ankur R. MDb, Brooks, James D. MDc, McKenney, Jesse K. MDa. The distribution of PAX-2 Immunoreactivity in the Prostate Gland, Seminal Vesicle, and Ejaculatory Duct: Comparison with Prostatic Adenocarcinoma and Discussion of Prostatic Zonal Embryogenesis. Human Pathology. 2010; 41: 1145–49.CrossRefGoogle ScholarPubMed

Harvey, Aaron M. MD, Grice, Beverly HTL, Hamilton, Candice HTL, Truong, Luan D. MD, Ro, Jae Y. MD, Ayala, Alberto G. MD, Zhai, Qihui ‘‘Jim’’ MD. Diagnostic Utility of P504S/p63 Cocktail Prostate-specific Antigen, and Prostatic Acid Phosphatase in Verifying Prostatic Carcinoma Involvement in Seminal Vesicles: A Study of 57 Cases of Radical Prostatectomy Specimens of Pathologic Stage pT3b. Arch Pathol Lab Med. 2010; 134: 983–88.CrossRefGoogle ScholarPubMed

Lopez-Beltran, A, Cheng, L, Blanca, A, Montironi, R. Cell Proliferation and Apoptosis in Prostate Needle Biopsies with Adenocarcinoma Gleason Score 6 or 7. Anal Quant Cytol Histol. 2012 Apr; 34(2): 61–65.Google Scholar

Scarpelli, M, Mazzucchelli, R, Barbisan, F, Santinelli, A, Lopez-Beltran, A, Cheng, L, Montironi, R. Is There a Role for Prostate Tumour Overexpressed-1 in the Diagnosis of HGPIN and of Prostatic Adenocarcinoma? A Comparison with Alpha-Methylacyl CoA Racemase. Int J Immunopathol Pharmacol. 2012 Jan–Mar; 25(1): 67–74.Google Scholar

Camparo, P, Egevad, L, Algaba, F, Berney, DM, Boccon-Gibod, L, Compérat, E, Evans, AJ, Grobholz, R, Kristiansen, G, Langner, C, Lopez-Beltran, A, Montironi, R, Oliveira, P, Vainer, B, Varma, M. Utility of Whole Slide Imaging and Virtual Microscopy in Prostate Pathology. APMIS. 2012 Apr; 120(4): 298–304. doi: 10.1111/j.1600-0463.2011.02872.x. Review.Google Scholar

Montironi, R, Scarpelli, M, Mazzucchelli, R, Cheng, L, Lopez-Beltran, A, Montorsi, F. Extent of Cancer of Less Than 50% in Any Prostate Needle Biopsy Core: How Many Millimeters Are There? Eur Urol. 2012 Apr; 61(4): 751–56. Epub 2012 Jan 5. No abstract available.Google Scholar

Cheng, L, Montironi, R, Bostwick, DG, Lopez-Beltran, A, Berney, DM. Staging of Prostate Cancer. Histopathology. 2012 Jan; 60(1): 87–117. doi: 10.1111/j.1365-2559.2011.04025.x.CrossRefGoogle ScholarPubMed

Montironi, R, Lopez-Beltran, A, Cheng, L, Scarpelli, M. Cervical-type Squamous Metaplasia and Myoepithelial Cell Differentiation in Stromal Tumor of the Prostate. Am J Surg Pathol. 2011 Nov; 35(11): 1752–54. No abstract available.CrossRefGoogle ScholarPubMed

Mazzucchelli, R, Barbisan, F, Santinelli, A, Lopez-Beltran, A, Cheng, L, Scarpelli, M, Montironi, R. Immunohistochemical Expression of Prostate Tumor Overexpressed 1 in Cystoprostatectomies with Incidental and Insignificant Prostate Cancer. Further Evidence for Field Effect in Prostatic Carcinogenesis. Hum Pathol. 2011 Dec; 42(12): 1931–36. Epub 2011 Jun 14.CrossRefGoogle ScholarPubMed

Williamson, SR, Zhang, S, Yao, JL, Huang, J, Lopez-Beltran, A, Shen, S, Osunkoya, AO, MacLennan, GT, Montironi, R, Cheng, L. ERG-TMPRSS2 Rearrangement Is Shared by Concurrent Prostatic Adenocarcinoma and Prostatic Small Cell Carcinoma and Absent in Small Cell Carcinoma of the Urinary Bladder: Evidence Supporting Monoclonal Origin. Mod Pathol. 2011 Aug; 24(8): 1120–27. doi: 10.1038/modpathol.2011.56.Google Scholar

Capitanio, U, Cheng, L, Lopez-Beltran, A, Scarpelli, M, Freschi, M, Montorsi, F, Montironi, R. The Importance of Interaction between Urologists and Pathologists in Incidental Prostate Cancer Management. Eur Urol. 2011 Jul; 60(1): 75–77.CrossRefGoogle ScholarPubMed

Montironi, R, Cheng, L, Lopez-Beltran, A, Mazzucchelli, R, Scarpelli, M. Editorial Comment to When Should We Expect No Residual Tumor (pT0) Once We Submit Incidental T1a-b Prostate Cancers to Radical Prostatectomy? Int J Urol. 2011 Feb; 18(2): 153–54. doi: 10.1111/j.1442-2042.2010.02717.x.Google Scholar

Mazzucchelli, R, Nesseris, I, Cheng, L, Lopez-Beltran, A, Montironi, R, Scarpelli, M. Active Surveillance for Low-risk Prostate cancer. Anticancer Res. 2010 Sep; 30(9): 3683–92.Google ScholarPubMed

Montironi, R, Mazzucchelli, R, Lopez-Beltran, A, Cheng, L. Words of Wisdom. Re: Peripheral Zone Prostate Cancers: Location and Intraprostatic Patterns of Spread at Histopathology. Eur Urol. 2010 Jul; 58(1): 180–82.Google Scholar

Montironi, R, Cheng, L, Lopez-Beltran, A, Scarpelli, M, Mazzucchelli, R, Mikuz, G, Kirkali, Z, Montorsi, F. Original Gleason System Versus 2005 ISUP Modified Gleason System: The Importance of Indicating Which System Is Used in the Patient’s Pathology and Clinical Reports. Eur Urol. 2010 Sep; 58(3): 369–73.Google Scholar

Montironi, R, Vela Navarrete, R, Lopez-Beltran, A, Mazzucchelli, R, Mikuz, G, Bono, AV. Histopathology Reporting of Prostate Needle Biopsies. 2005 Update. Virchows Arch. 2006; 449(1): 1–13.Google Scholar

Lopez-Beltran, A, Mikuz, G, Luque, RJ, Mazzucchelli, R, Montironi, R. Current Practice of Gleason Grading of Prostate Carcinoma. Virchows Arch. 2006 Feb; 448(2): 111–18.CrossRefGoogle ScholarPubMed

Epstein, JI, Allsbrook, WC, Amin, MB, Egevad, LL, Bastacky, S, Lopez-Beltran, A, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2005; 29: 1228–42.Google Scholar

Lopez-Beltran, A, Qian, Junqi, Montironi, Rodolfo, Luque, Rafael J, Bostwick, David G. Atypical Adenomatous Hyperplasia (Adenosis) of the Prostate: DNA Ploidy Analysis and Immunophenotype. Int J Surgical Pathology. 2005; 13: 167–73.Google Scholar

Lopez-Beltran, A, Eble, John N, Bostwick, David G. Pleomorphic Giant Cell Carcinoma of the Prostate. Archives of Pathology and Laboratory Medicine. 2005; 129: 683–85.Google Scholar

Montironi, R, Scattoni, V, Mazzucchelli, R, Lopez-Beltran, A, Bostwick, DG, Montorsi, F. Atypical Foci Suspicious but Not Diagnostic of Malignancy in Prostate Needle Biopsies (Also Referred to as “Atypical Small Acinar Proliferation Suspicious for but Not Diagnostic of Malignancy”). Eur Urol. 2006 Oct; 50(4): 666–74.Google Scholar

De Marzo, AM, Platz, EA, Epstein, JI, Ali, T, Billis, A, Chan, TY, Cheng, L, Datta, M, Egevad, L, Ertoy-Baydar, D, Farre, X, Fine, SW, Iczkowski, KA, Ittmann, M, Knudsen, BS, Loda, M, Lopez-Beltran, A, Magi-Galluzzi, C, Mikuz, G, Montironi, R, Pikarsky, E, Pizov, G, Rubin, MA, Samaratunga, H, Sebo, T, Sesterhenn, IA, Shah, RB, Signoretti, S, Simko, J, Thomas, G, Troncoso, P, Tsuzuki, TT, van Leenders, GJ, Yang, XJ, Zhou, M, Figg, WD, Hoque, A, Lucia, MS. A Working Group Classification of Focal Prostate Atrophy Lesions. Am J Surg Pathol. 2006 Oct; 30(10): 1281–91.CrossRefGoogle Scholar

Marks, RA, Koch, MO, Lopez-Beltran, A, Montironi, R, Juliar, BE, Cheng, L. The Relationship between the Extent of Surgical Margin Positivity and Prostate Specific Antigen Recurrence in Radical Prostatectomy Specimens. Hum Pathol. 2007 Aug; 38(8): 1207–11.Google Scholar

Cheng, L, Bishop, E, Zhou, H, Maclennan, GT, Lopez-Beltran, A, Zhang, S, Badve, S, Baldridge, LA, Montironi, R. Lymphatic Vessel Density in Radical Prostatectomy Specimens. Hum Pathol. 2008 Apr; 39(4): 610–15.CrossRefGoogle ScholarPubMed

Cheng, L, MacLennan, GT, Abdul-Karim, FW, Lopez-Beltran, A, Montironi, R. Eosinophilic Metaplasia of the Prostate: A Newly Described Lesion Distinct from Other Eosinophilic Changes in Prostatic Epithelium. Anal Quant Cytol Histol. 2008 Aug; 30(4): 226–30.Google ScholarPubMed

Mazzucchelli, R, Lopez-Beltran, A, Cheng, L, Scarpelli, M, Kirkali, Z, Montironi, R. Rare and Unusual Histological Variants of Prostatic Carcinoma: Clinical Significance. BJU Int. 2008 Nov; 102(10): 1369–74.Google Scholar

Mazzucchelli, R, Morichetti, D, Lopez-Beltran, A, Cheng, L, Scarpelli, M, Kirkali, Z, Montironi, R. Neuroendocrine Tumours of the Urinary System and Male Genital Organs: Clinical Significance. BJU Int. 2009 Jun; 103(11): 1464–70. Epub 2009 Feb 27. Review.Google Scholar

Montironi, R, Cheng, L, Mazzucchelli, R, Lopez-Beltran, A. Pathological Definition and Difficulties in Assessing Positive Margins in Radical Prostatectomy Specimens. BJU Int. 2009 Feb; 103(3): 286–88.Google Scholar

Lopez-Beltran, A, Cheng, L, Prieto, R, Blanca, A, Montironi, R. Lymphoepithelioma-like Carcinoma of the Prostate. Hum Pathol. 2009 Jul; 40(7): 982–87.CrossRefGoogle ScholarPubMed

Montironi, R, Cheng, L, Lopez-Beltran, A, Mazzucchelli, R, Scarpelli, M, Kirkali, Z, Montorsi, F. Joint Appraisal of the Radical Prostatectomy Specimen by the Urologist and the Uropathologist: Together, We Can Do It Better. Eur Urol. 2009 Dec; 56(6): 951–55.Google Scholar

Morichetti, D, Mazzucchelli, R, Lopez-Beltran, A, Cheng, L, Scarpelli, M, Kirkali, Z, Montorsi, F, Montironi, R. Secondary Neoplasms of the Urinary System and Male Genital Organs. BJU Int. 2009 Sep; 104(6): 770–76.Google Scholar